James Kelly Ganjei - Jun 22, 2021 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Director
Signature
/s/ James Kelly Ganjei
Stock symbol
INMB
Transactions as of
Jun 22, 2021
Transactions value $
$0
Form type
4
Date filed
6/24/2021, 05:52 PM
Next filing
Mar 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +19K $0.00 19K Jun 22, 2021 Common Stock 19K $17.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Option represents a right to receive one share of common stock of INmune Bio, Inc.
F2 Options granted pursuant to the Company's 2021 Stock Incentive Plan. These Options vest on a pro rata quarterly basis over three years such that all options to purchase the 19,025 shares will have vested on the third anniversary of the grant date.